0
     

Report Added
Report already added
Consumer Health in Israel

Consumer Health in Israel

Consumer health is expected to register a healthy retail value sales growth in 2022. After a successful vaccination programme in 2021, society opened up quickly. As a result of the opening up, winter illnesses such as the common cold spread more easily, and product areas such as cough and cold remedies saw a strong recovery. With schools also open, lice infestations were more widespread again, leading to increased value sales for lice treatments. These dynamics remain prevalent in 2022, in fact,...

Euromonitor International's Consumer Health in Israel report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2017-2021, allowing you to identify the sectors driving growth. Forecasts to 2026 illustrate how the market is set to change.

Product coverage: Allergy Care, Herbal/Traditional Products, OTC, Paediatric Consumer Health, Sports Nutrition, Vitamins and Dietary Supplements, Weight Management and Wellbeing.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
* Get a detailed picture of the Consumer Health market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.
Consumer Health in Israel

List Of Contents And Tables

CONSUMER HEALTH IN ISRAEL
EXECUTIVE SUMMARY
Consumer health in 2022: The big picture
2022 key trends
Competitive landscape
Retailing developments
What next for consumer health?
MARKET INDICATORS
Table 1 Consumer Expenditure on Health Goods and Medical Services: Value 2017-2022
Table 2 Life Expectancy at Birth 2017-2022
MARKET DATA
Table 3 Sales of Consumer Health by Category: Value 2017-2022
Table 4 Sales of Consumer Health by Category: % Value Growth 2017-2022
Table 5 NBO Company Shares of Consumer Health: % Value 2018-2022
Table 6 LBN Brand Shares of Consumer Health: % Value 2019-2022
Table 7 Penetration of Private Label in Consumer Health by Category: % Value 2017-2022
Table 8 Distribution of Consumer Health by Format: % Value 2017-2022
Table 9 Distribution of Consumer Health by Format and Category: % Value 2022
Table 10 Forecast Sales of Consumer Health by Category: Value 2022-2027
Table 11 Forecast Sales of Consumer Health by Category: % Value Growth 2022-2027
APPENDIX
OTC registration and classification
Vitamins and dietary supplements registration and classification
Self-medication/self-care and preventive medicine
Switches
DISCLAIMER
DEFINITIONS
SOURCES
Summary 1 Research Sources
ANALGESICS IN ISRAEL
KEY DATA FINDINGS
2022 DEVELOPMENTS
Return of seasonal flu supports value sales
Teva Pharmaceutical Industries continues to lead and private label continues to gain share
E-commerce continues to gain value share
PROSPECTS AND OPPORTUNITIES
Lifting of mask mandate likely to increase flu activity
Analgesics innovate through further segmentation
New chemists/pharmacies retail outlets likely to stimulate price competition and growth
CATEGORY DATA
Table 12 Sales of Analgesics by Category: Value 2017-2022
Table 13 Sales of Analgesics by Category: % Value Growth 2017-2022
Table 14 NBO Company Shares of Analgesics: % Value 2018-2022
Table 15 LBN Brand Shares of Analgesics: % Value 2019-2022
Table 16 Forecast Sales of Analgesics by Category: Value 2022-2027
Table 17 Forecast Sales of Analgesics by Category: % Value Growth 2022-2027
COUGH, COLD AND ALLERGY (HAY FEVER) REMEDIES IN ISRAEL
KEY DATA FINDINGS
2022 DEVELOPMENTS
Back-to-school and the return of cold and flu season
Teva Pharmaceutical Industries continues to lead and private label gains share
Consumers look for natural, home-made remedies 
PROSPECTS AND OPPORTUNITIES
Normalisation of public life maintains value sales
Immune-boosting properties remain popular
Antihistamines/allergy remedies see further growth
CATEGORY DATA
Table 18 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2017-2022
Table 19 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2017-2022
Table 20 NBO Company Shares of Cough, Cold and Allergy (Hay Fever) Remedies: % Value 2018-2022
Table 21 LBN Brand Shares of Cough, Cold and Allergy (Hay Fever) Remedies: % Value 2019-2022
Table 22 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2022-2027
Table 23 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2022-2027
DIGESTIVE REMEDIES IN ISRAEL
KEY DATA FINDINGS
2022 DEVELOPMENTS
Demand for digestive remedies remains constant as eating out leads to more unhealthy eating
Conflicting trends at play in digestive remedies
GSK Consumer Healthcare faces increasing competition from medical devices, prescription medication, and lifestyle changes
PROSPECTS AND OPPORTUNITIES
Healthier eating could dampen growth rates over forecast period
Private label and e-commerce gain value share over forecast period
Developments in herbal products will lead the way for health-conscious consumers
CATEGORY DATA
Table 24 Sales of Digestive Remedies by Category: Value 2017-2022
Table 25 Sales of Digestive Remedies by Category: % Value Growth 2017-2022
Table 26 NBO Company Shares of Digestive Remedies: % Value 2018-2022
Table 27 LBN Brand Shares of Digestive Remedies: % Value 2019-2022
Table 28 Forecast Sales of Digestive Remedies by Category: Value 2022-2027
Table 29 Forecast Sales of Digestive Remedies by Category: % Value Growth 2022-2027
DERMATOLOGICALS IN ISRAEL
KEY DATA FINDINGS
2022 DEVELOPMENTS
Opening of schools leads to boost in value sales for lice treatments
Hair loss treatments benefits from pandemic
Perrigo Israel Pharmaceuticals maintains its lead
PROSPECTS AND OPPORTUNITIES
Moderate growth over the forecast period
Private label fight to gain value share
Social stigma of certain products benefits online sales
CATEGORY DATA
Table 30 Sales of Dermatologicals by Category: Value 2017-2022
Table 31 Sales of Dermatologicals by Category: % Value Growth 2017-2022
Table 32 NBO Company Shares of Dermatologicals: % Value 2018-2022
Table 33 LBN Brand Shares of Dermatologicals: % Value 2019-2022
Table 34 LBN Brand Shares of Hair Loss Treatments: % Value 2019-2022
Table 35 Forecast Sales of Dermatologicals by Category: Value 2022-2027
Table 36 Forecast Sales of Dermatologicals by Category: % Value Growth 2022-2027
NRT SMOKING CESSATION AIDS IN ISRAEL
KEY DATA FINDINGS
2022 DEVELOPMENTS
More people try to give up smoking as smokers are more severely affected by COVID-19
Nicotinell – virtually the only brand present
Alternative therapies for giving up smoking gaining traction
PROSPECTS AND OPPORTUNITIES
Shrinking user base set to limit growth
Stamp down on e-vapour products boosts value sales
Little innovation expected
CATEGORY INDICATORS
Table 37 Number of Smokers by Gender 2017-2022
CATEGORY DATA
Table 38 Sales of NRT Smoking Cessation Aids by Category: Value 2017-2022
Table 39 Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2017-2022
Table 40 NBO Company Shares of NRT Smoking Cessation Aids: % Value 2018-2022
Table 41 LBN Brand Shares of NRT Smoking Cessation Aids: % Value 2019-2022
Table 42 Forecast Sales of NRT Smoking Cessation Aids by Category: Value 2022-2027
Table 43 Forecast Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2022-2027
SLEEP AIDS IN ISRAEL
KEY DATA FINDINGS
2022 DEVELOPMENTS
Heightened anxiety due to political unrest supports value sales for sleep aids
Consumers look for natural ingredients
Neopharm Import (Israel) 1966 continues to lead but faces increasing competition
PROSPECTS AND OPPORTUNITIES
Greater acceptance of sleep aids leads to value growth
Players continue to innovate
E-commerce big winner from pandemic
CATEGORY DATA
Table 44 Sales of Sleep Aids: Value 2017-2022
Table 45 Sales of Sleep Aids: % Value Growth 2017-2022
Table 46 NBO Company Shares of Sleep Aids: % Value 2018-2022
Table 47 LBN Brand Shares of Sleep Aids: % Value 2019-2022
Table 48 Forecast Sales of Sleep Aids: Value 2022-2027
Table 49 Forecast Sales of Sleep Aids: % Value Growth 2022-2027
EYE CARE IN ISRAEL
KEY DATA FINDINGS
2022 DEVELOPMENTS
Strong performance as extended times spent on screens leads to strained eyes
Lapidot Medical Import and Marketing extends its lead
Shift to higher-priced products
PROSPECTS AND OPPORTUNITIES
Outlook very positive over forecast period
Allergy eye care is expected to see high growth due to climate change
Natural positioning key part of messaging
CATEGORY DATA
Table 50 Sales of Eye Care by Category: Value 2017-2022
Table 51 Sales of Eye Care by Category: % Value Growth 2017-2022
Table 52 NBO Company Shares of Eye Care: % Value 2018-2022
Table 53 LBN Brand Shares of Eye Care: % Value 2019-2022
Table 54 Forecast Sales of Eye Care by Category: Value 2022-2027
Table 55 Forecast Sales of Eye Care by Category: % Value Growth 2022-2027
WOUND CARE IN ISRAEL
KEY DATA FINDINGS
2022 DEVELOPMENTS
Recovery in growth as society opens up
Chemipal extends its lead but strong growth for private label threatens its position
Growing variety of printed plasters
PROSPECTS AND OPPORTUNITIES
Recovery picks up as society reopens
Private label gains value share
Innovation needed to stand out from competition
CATEGORY DATA
Table 56 Sales of Wound Care by Category: Value 2017-2022
Table 57 Sales of Wound Care by Category: % Value Growth 2017-2022
Table 58 NBO Company Shares of Wound Care: % Value 2018-2022
Table 59 LBN Brand Shares of Wound Care: % Value 2019-2022
Table 60 Forecast Sales of Wound Care by Category: Value 2022-2027
Table 61 Forecast Sales of Wound Care by Category: % Value Growth 2022-2027
VITAMINS IN ISRAEL
KEY DATA FINDINGS
2022 DEVELOPMENTS
Heightened health awareness continues to support growth in vitamins
Ta’am Teva-Altman General Partnership maintains its lead and Ambrosia Ltd Solgar Israel loses share
E-commerce continues to thrive
PROSPECTS AND OPPORTUNITIES
Healthy value growth, supported by heightened consumer health awareness
Increasing segmentation over forecast period
Innovation in formats over forecast period
CATEGORY DATA
Table 62 Sales of Vitamins by Category: Value 2017-2022
Table 63 Sales of Vitamins by Category: % Value Growth 2017-2022
Table 64 Sales of Multivitamins by Positioning: % Value 2017-2022
Table 65 NBO Company Shares of Vitamins: % Value 2018-2022
Table 66 LBN Brand Shares of Vitamins: % Value 2019-2022
Table 67 Forecast Sales of Vitamins by Category: Value 2022-2027
Table 68 Forecast Sales of Vitamins by Category: % Value Growth 2022-2027
DIETARY SUPPLEMENTS IN ISRAEL
KEY DATA FINDINGS
2022 DEVELOPMENTS
Healthy value growth, but lower than during the height of the pandemic
Ta’am Teva-Altman General Partnership maintains its lead, while Ambrosia Ltd Solgar Israel remains in second place
E-commerce continues its upward trajectory
PROSPECTS AND OPPORTUNITIES
Moderate outlook over forecast period
Holistic approach to health drives value sales 
More targeted solutions over forecast period
CATEGORY DATA
Table 69 Sales of Dietary Supplements by Category: Value 2017-2022
Table 70 Sales of Dietary Supplements by Category: % Value Growth 2017-2022
Table 71 Sales of Dietary Supplements by Positioning: % Value 2017-2022
Table 72 NBO Company Shares of Dietary Supplements: % Value 2018-2022
Table 73 LBN Brand Shares of Dietary Supplements: % Value 2019-2022
Table 74 Forecast Sales of Dietary Supplements by Category: Value 2022-2027
Table 75 Forecast Sales of Dietary Supplements by Category: % Value Growth 2022-2027
WEIGHT MANAGEMENT AND WELLBEING IN ISRAEL
KEY DATA FINDINGS
2022 DEVELOPMENTS
Value growth static as consumers increasingly shun crash diet products
Herbalife International of Israel (1990) continues to lead, while Oriental Secrets loses share due to the dramatic declines in slimming teas
Supplement nutrition drinks registers positive value growth
PROSPECTS AND OPPORTUNITIES
Bleak outlook for weight loss products
E-commerce continues to grow at healthy pace
Slimming teas loose further ground
CATEGORY DATA
Table 76 Sales of Weight Management and Wellbeing by Category: Value 2017-2022
Table 77 Sales of Weight Management and Wellbeing by Category: % Value Growth 2017-2022
Table 78 NBO Company Shares of Weight Management and Wellbeing: % Value 2018-2022
Table 79 LBN Brand Shares of Weight Management and Wellbeing: % Value 2019-2022
Table 80 Forecast Sales of Weight Management and Wellbeing by Category: Value 2022-2027
Table 81 Forecast Sales of Weight Management and Wellbeing by Category: % Value Growth 2022-2027
SPORTS NUTRITION IN ISRAEL
KEY DATA FINDINGS
2022 DEVELOPMENTS
Sports nutrition continues to see positive growth as more and more people adopt a healthy and physically active lifestyle
Meditrend continues to lead in 2022
E-commerce continues its upward trajectory
PROSPECTS AND OPPORTUNITIES
Rosy outlook over forecast period
Protein enters the mainstream
Growth supported by dietary trends
CATEGORY DATA
Table 82 Sales of Sports Nutrition by Category: Value 2017-2022
Table 83 Sales of Sports Nutrition by Category: % Value Growth 2017-2022
Table 84 NBO Company Shares of Sports Nutrition: % Value 2018-2022
Table 85 LBN Brand Shares of Sports Nutrition: % Value 2019-2022
Table 86 Forecast Sales of Sports Nutrition by Category: Value 2022-2027
Table 87 Forecast Sales of Sports Nutrition by Category: % Value Growth 2022-2027
HERBAL/TRADITIONAL PRODUCTS IN ISRAEL
KEY DATA FINDINGS
2022 DEVELOPMENTS
Sleeps aids best performer due to anxiety around security
Ta’am Teva-Altman General Partnership retains its lead and private label extends its share in 2022
A holistic approach to health contributes to growth
PROSPECTS AND OPPORTUNITIES
Healthy value growth over forecast period
Online space key battleground over forecast period
Paediatric products grow strongly over forecast period
CATEGORY DATA
Table 88 Sales of Herbal/Traditional Products by Category: Value 2017-2022
Table 89 Sales of Herbal/Traditional Products by Category: % Value Growth 2017-2022
Table 90 NBO Company Shares of Herbal/Traditional Products: % Value 2018-2022
Table 91 LBN Brand Shares of Herbal/Traditional Products: % Value 2019-2022
Table 92 Forecast Sales of Herbal/Traditional Products by Category: Value 2022-2027
Table 93 Forecast Sales of Herbal/Traditional Products by Category: % Value Growth 2022-2027
PAEDIATRIC CONSUMER HEALTH IN ISRAEL
KEY DATA FINDINGS
2022 DEVELOPMENTS
With schools open, common cold spreads again leading to increased value sales of cough/cold remedies
Teva Pharmaceutical Industries maintains its lead and Ta’am Teva-Altman General Partnership retains its second place, while private label increases its share in 2020
Players focus on child-friendly design
PROSPECTS AND OPPORTUNITIES
Demographic trends to dominate with normalisation
Shift towards natural products over forecast period
Hectic lifestyles expected to encourage parents to provide paediatric vitamins and dietary supplements to their children
CATEGORY DATA
Table 94 Sales of Paediatric Consumer Health by Category: Value 2017-2022
Table 95 Sales of Paediatric Consumer Health by Category: % Value Growth 2017-2022
Table 96 Sales of Paediatric Vitamins and Dietary Supplements by Type: % Value 2017-2022
Table 97 NBO Company Shares of Paediatric Consumer Health: % Value 2018-2022
Table 98 LBN Brand Shares of Paediatric Consumer Health: % Value 2019-2022
Table 99 Forecast Sales of Paediatric Consumer Health by Category: Value 2022-2027
Table 100 Forecast Sales of Paediatric Consumer Health by Category: % Value Growth 2022-2027

Report Title: Consumer Health in Israel


Your Details
Valid Invalid number

SELECT A FORMAT

ADD TO CART BUY NOW